New gene therapies that can come with a one-time cost of more than $2 million also are having an impact, insurance brokers ...

Regular blood testing to check for toxicity from standard rheumatoid arthritis drugs is recommended. Results of this ...

Moderate-to-severe traumatic brain injury (TBI) increased malignant brain tumor risk in a large retrospective study of ...

"The Mediterranean diet, rich in fiber, whole grains, antioxidants, and anti-inflammatory compounds, is known to reduce ...

Across 99 studies examining the effects of high-concentration THC products on mental health outcomes, 70% of the ...

The Alliance for Natural Health joined Xlear in a separate petition in May demanding that the FTC drop its requirement for ...

A recent analysis of industry payment data showed that more than $12 billion in payments were made to physicians from 2013 to ...

HHS has moved to strip thousands of federal health agency employees of their collective bargaining rights, according to a ...

Noncancer ("off-target") mortality increased by 0.2% in screened versus non-screened patients. Separate analyses of the individual studies yielded relative risk (RR) values of 0.89 to 1.09 for ...

The PCSK9 inhibitor evolocumab (Repatha) got the FDA's blessing for cardiovascular protection, with or without a history of cardiovascular disease (CVD).

In a fact sheet, the agency noted that high concentrations of oxygen pose a risk for fire, "which is one reason why the FDA recommends treatment at an accredited facility. Explosions and fires have ...